NCT07771803
- Conditions
- AML (Acute Myeloid Leukemia), Disease Attributes, Hematologic Diseases, +10 more
- Locations
-
- MDA at Cooper University Health Care Camden, New Jersey, United States
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,359 public trials
538 recruiting studies
Recurrence trial results
NCT07105059
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT06927466
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
- Locations
-
- Peking University People's Hospital Beijing, China
- Jiangxi Province pediatric hospital Nanchang, China
- The First Affiliated Hospital of Nanchang University Nanchang, China
- Children's Hospital of Shanghai Shanghai, China
NCT02203903
- Conditions
- Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +11 more
- Locations
-
- Childrens National Medical Center Washington D.C., District of Columbia, United States
- Tania Jain, MD Baltimore, Maryland, United States
NCT06459024
- Conditions
- Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Disease Attributes, +10 more
- Locations
-
- University Hospital Aachen Aachen, Germany
- University Hospital Greifswald Greifswald, Germany
- University Hospital Halle Halle, Germany
- University Hospital of Rostock Rostock, Germany
NCT06149286
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States
- Indiana University and Comprehensive Cancer Center Indianapolis, Indiana, United States
- Hattiesburg Clinic Hattiesburg, Mississippi, United States
Recruiting
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
NCT06980116
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
- Locations
-
- LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
- IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
- Hospital Beata Maria Ana Madrid, Spain
- Hospital Fundación Jiménez Diaz Madrid, Spain
NCT07570407
- Conditions
- Acute Myeloid Leukemia, Allogeneic HSCT, Disease Attributes, +13 more
- Locations
-
- University Hospital Pilsen Pilsen, Czechia
NCT07280013
- Conditions
- Bites and Stings, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- UC Davis Comprehensive Cancer Center Sacramento, California, United States
- UCLA Health, Jonsson Comprehensive Cancer Center Santa Monica, California, United States
- University of Florida Gainesville, Florida, United States
Recruiting
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
NCT06340737
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
- Locations
-
- Stanford University Palo Alto, California, United States